Drug Profile
Erythropoietin long-acting - Hanmi Pharmaceutical
Alternative Names: HM10760A; LAPS-EPO; Long-acting erythropoietin - HanmiLatest Information Update: 20 Apr 2016
Price :
$50
*
At a glance
- Originator Hanmi Pharmaceutical
- Class Antianaemics; Erythropoietins
- Mechanism of Action Erythropoiesis stimulants; Erythropoietin receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Anaemia
Most Recent Events
- 30 Nov 2009 Phase-I clinical trials in Anaemia in South Korea (IV)
- 31 Oct 2009 Phase-I clinical trials in Anaemia in USA (IV)